21 May 2009
The inï¬‚uence of cyclosporine a and rapamycin on the expression of CD11b and CD57 within CD8+CD28- population in renal allograft recipientsA Korecka-Polak, P Wierzbicki, A Duszota, K Bocian, M Niemczyk, D Klosowska, J Wyzgal, L Paczek, A Chmura, M Durlik, A Gorski, G Korczak-Kowalska
Ann Transplant 2009; 14(1): 37-38 :: ID: 880334
Background: The function of the allograft seems to be dependent on the level of regulatory lymphocytes including CD8+CD28- cells. This is a heterogonous population containing both suppressor (Ts) and cytotoxic cells (Tc). It is possible that adhesive molecules CD11b and CD57 can be helpful to distinguish between Ts and Tc subpopulations. The aim of this study was to evaluate the differences in the expression of CD11b and CD57 within CD8+CD28- population in renal allograft recipients with different immunosuppressive regimens (CsA or RAPA) and different graft's function.
Material/Methods: Peripheral blood was obtained from the healthy volunteers
and patients divided into four groups: CsA-Sta, RAPA-Sta, CsA-CR, RAPA-CR.
Sta - stable graft function; CR - chronic graft rejection; CsA - cyclosporine A,
azathioprine, prednisone; RAPA - rapamycin, prednisone. Peripheral blood
mononuclear cells were labelled with mouse anti-human mAbs conjugated with ï¬‚uorochromes and analyzed by ï¬‚ow cytometry (FACSCalibur).
Results: In CsA-Sta group the expression of CD11b within CD8+CD28- population was lower than in the healthy volunteers. The expression of CD57 within CD8+CD28- population in RAPA-Sta group was higher than in the healthy volunteers, CsA-Sta and CsA-CR groups. In the group with the biggest variation in the number of HLA donor/recipients mismatches - CsA-CR, we observed some correlations between the number of HLA mismatches and the expression of CD11b and CD57 within CD8+CD28- population: positive for CD57 and HLA-DR, negative for CD11b and HLA-A, positive for CD11b and HLA-B.
Conclusions: The expression of CD11b and CD57 within CD8+CD28- population in renal allograft recipients seems to be dependent not only on the type of immunosuppressive regimen but also on the number of HLA mismatches between the donor and recipient. Therefore both of these factors can inï¬‚uence the ratio Ts: Tc in heterogonous CD8+CD28- population.
Keywords: Immunosuppression, Kidney Transplantation
06 May 2022 : Original articlePhosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of D...
Ann Transplant In Press; DOI: 10.12659/AOT.936293
Most Viewed Current Articles
31 Dec 1969 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588
31 Dec 1969 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
31 Dec 1969 : Review articleKidney Transplantation in the Times of COVID-19 – A Literature Review
Ann Transplant 2020; 25:e925755